SEARCH

SEARCH BY CITATION

References

  • AGUILAR-BRYAN, L., NICHOLS, C.G., WECHSLER, S.W., CLEMENT IV, J.P., BOYD, A.E., GONZALEZ, G., HERRERA-SOSA, H., NGUY, K., BRYAN, J. & NELSON, D.A. (1995). Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science, 268, 423426.
  • ASHFIELD, R., GRIBBLE, F.M., ASHCROFT, S.J. & ASHCROFT, F.M. (1999). Identification of the high-affinity tolbutamide site on the SUR1subunit of the KATP channel. Diabetes, 48, 13411347.
  • BABENKO, A.P., GONZALEZ, G. & BRYAN, J. (2000). Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of KATP channel isoforms are required for selective interaction with K+ channel openers. J. Biol. Chem., 275, 717720.
  • CHUTKOW, W.A., SIMON, M.C., LE BEAU, M.M. & BURANT, C.F. (1996). Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes, 45, 14391445.
  • CLEMENT IV, J.P., KUNJILWAR K GONZALEZ, G., SCHWANSTESCHERM, M., PANTEN, U., AGUILAR-BRYAN, L. & BRYAN, J. (1997). Association and stoichiometry of KATP channel subunits. Neuron, 18, 827838.
  • CUI, Y., TINKER, A. & CLAPP, L.H. (2003). Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A. Br. J. Pharmacol., 139, 122128.
  • DUNNE, M.J. & PETERSEN, O.H. (1986). Intracellular ADP activates K+ channels that are inhibited by ATP in an insulin-secreting cell line. FEBS Lett., 208, 5862.
  • GIBLIN, J.P., LEANEY, J.L. & TINKER, A. (1999). The molecular assembly of ATP-sensitive potassium channels: determinants on the pore forming subunit. J. Biol. Chem., 274, 2265222659.
  • GUILLEMARE, E., HONORE, E., DE WEILLE, J., FOSSET, M., LAZDUNSKI, M. & MEISHERI, K. (1994). Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells. Mol. Pharmacol., 46, 139145.
  • HIGDEN, N.R., XU, X., KHAN, S.A., WANG, J., LEE, K. & MEISHERI, K.D. (1995). Selective vascular KATP channel blockade by U-37883A: comparison with cardiac KATP channel. FASEB J., 9, A614.
  • HUMPHREY, S.J. (1999). Pharmacology of the KATP channel blocking morpholinoguanidine PNU-37883A. Cardiovasc. Drug Rev., 17, 295328.
  • INAGAKI, N., GONOI, T., CLEMENT IV, J.P., NAMBA, N., INAZAWA, J., GONZALEZ, G., AGUILAR-BRYAN, L., SEINO, S. & BRYAN, J. (1995b). Reconstitution of IKATP: an inward rectifier subunit plus the sulphonylurea receptor. Science, 270, 11661169.
  • INAGAKI, N., GONOI, T., CLEMENT IV, J.P., WANG, C.Z., AGUILAR-BRYAN, L., BRYAN, J. & SEINO, S. (1996). A family of sulfonylurea receptors determines the properties of ATP-sensitive K+ channels. Neuron, 16, 10111017.
  • INAGAKI, N., GONOI, T. & SEINO, S. (1997). Subunit stoichiometry of the pancreatic beta-cell ATP-sensitive K+ channel. FEBS Lett., 409, 232236.
  • INAGAKI, N., TSUURA, Y., NAMBA, N., MASUDA, K., GONOI, T., HORIE, M., SEINO, Y., MIZUTA, M. & SEINO, S. (1995a). Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J. Biol. Chem., 270, 56915694.
  • ISOMOTO, S., KONDO, C., YAMADA, M., MATSUMOTO, S., HIGASHIGUCHI, O., HORIO, Y., MATSUZAWA, Y. & KURACHI, Y. (1996). A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J. Biol. Chem., 271, 2432124324.
  • KAKEI, M., KELLY, R.P., ASHCROFT, S.J.H. & ASHCROFT, F.M. (1986). The ATP-sensitivity of K+ channels in rat pancreatic B-cells is modulated by ADP. FEBS Lett., 208, 6366.
  • KONDO, C., REPUNTE, V.P., SATOH, E., YAMADA, M., HORIO, Y., MATSUZAWA, Y., POTT, L. & KURACHI, Y. (1998). Chimeras of Kir6.1 and Kir6.2 reveal structural elements involved in spontaneous opening and unitary conductance of the ATP-sensitive K+ channels. Recept. Channel, 6, 129140.
  • KOVALEV, H., LODWICK, D. & QUAYLE, J.M. (2001). Inhibition of cloned KATP channels by the morpholinoguanidine PNU-37883A. J. Physiol. (Lond.), 531P, S173.
  • LÖFFLER-WALZ, C. & QUAST, U. (1998). Interaction of the diuretics torasemide and U-37883A with the KATP channel in rat isolated aorta. Naunyn-Schmiedeberg's Arch. Pharmacol., 358, 230237.
  • MEISHERI, K.D., HUMPHREY, S.J., KHAN, S.A., CIPKUS-DUBRAY, L.A., SMITH, M.P. & JONES, A.W. (1993). 4-morpholinecarboximidine-N-1-adamantyl-N′-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers. J. Pharmacol. Exp. Ther., 266, 655665.
  • OHRNBERGER, C.E., KHAN, S.A. & MEISHERI, K.D. (1993). Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists. J. Pharmacol. Exp. Ther., 267, 2530.
  • OLEYNEK, J. & MEISHERI, K. (1992). Intact tissue binding characteristics of 3H-U-37883A, a vascular KATP antagonist. FASEB J., 6, A1778.
  • QUAYLE, J.M., NELSON, M.T. & STANDEN, N.B. (1997). Inward rectifier and ATP-sensitive potassium channels in arterial smooth muscle. Physiol. Rev., 77, 11651232.
  • ROBERTSON, D.W. & STEINBERG, M.L. (1990). Potassium channel modulators: scientific applications and therapeutic promise. J. Med. Chem., 33, 15291541.
  • SAKURA, H., AMMALA, C., SMITH, P.A., GRIBBLE, F.M. & ASHCROFT, F.M. (1995). Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle. FEBS Lett., 377, 338344.
  • SCHWAPPACH, B., ZERANGUE, N., JAN, Y.N. & JAN, L.Y. (2000). Molecular basis for KATP assembly: transmembrane interactions mediate association of a K+ channel with an ABC transporter. Neuron, 26, 155167.
  • SEINO, S. & MIKI, T. (2003). Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog. Biophys. Mol. Biol., 81, 133176.
  • SHYNG, S.-L. & NICHOLS, C.G. (1997). Octameric stoichiometry of the KATP channel complex. J. Gen. Physiol., 110, 655664.
  • STURGESS, N.C., ASHFORD, M.L., COOK, D.L. & HALES, C.N. (1985). The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet, 2, 474475.
  • SURAH-NARWAL, S., XU, S.Z., MCHUGH, D., MCDONALD, R.L., HOUGH, E., CHEONG, A., PARTRIDGE, C., SIVAPRASADARAO, A. & BEECH, D.J. (1999). Block of human aorta Kir6.1 by the vascular KATP channel inhibitor U37883A. Br. J. Pharmacol., 128, 667672.
  • TAKANO, M., XIE, L.-H., OTANI, H. & HORIE, M. (1998). Cytoplasmic terminus domains of Kir6.x confer different nucleotide-dependent gating on the ATP-sensitive K+ channel. J. Physiol. (Lond.), 512, 395406.
  • TUCKER, S.J., GRIBBLE, F.M., ZHAO, C., TRAPP, S. & ASHCROFT, F.M. (1997). Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature, 387, 179183.
  • UHDE, I., TOMAN, A., GROSS, I. & SCWANSTECHER, M. (1999). Identification of the potassium channel opener site on sulfonylurea receptors. J. Biol. Chem., 274, 2807928082.
  • WELLMAN, G.C., BARRETT-JOLLEY, R., KÖPPEL, H., EVERITT, D. & QUAYLE, J.M. (1999). Inhibition of vascular KATP channels by U-37883A: a comparison with cardiac and skeletal muscle. Br. J. Pharmacol., 128, 909916.
  • YAMADA, M., ISOMOTO, S., MATSUMOTO, S., KONDO, C., SHINDO, T., HORIO, Y. & KURACHI, Y. (1997). Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel. J. Physiol. (Lond.), 499, 715720.
  • ZERANGUE, N., SCHWAPPACH, B., JAN, Y.N. & YAN, L.Y. (1999). A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane KATP channels. Neuron, 22, 537548.